Skip to content
DA5DA5DA5JPJPJP

Drawing based on the description in the official product monograph. No photo yet.

“5 mg tablets are yellow coloured biconvex, round shaped, film coated tablets with "DA5" engraved on one side and "JP" engraved on another side”

DA5 JP pill

Pill with imprint DA5 JP is yellow, round and has been identified as Dapagliflozin 5 mg. It is used for heart failure and type 2 diabetes. It is supplied by Angita Pharma Inc.

Sold in Canada

Dapagliflozin 5 mg

Brand
AG-Dapagliflozin
Imprint
DA5 JP
Strength
5 mg
Used for
Heart failure and type 2 diabetes
Color
Yellow
Shape
Round
Form
Tablet
Manufacturer
Angita Pharma Inc
Drug class
Diabetes medicine (SGLT2 inhibitor)
Sold in
Canada
DIN
02533049

Source: Health Canada's Drug Product Database and the official product monograph. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Dapagliflozin pills and guides

What is Dapagliflozin used for?

Dapagliflozin is used for heart failure and type 2 diabetes.

Medicine type
Diabetes medicine (SGLT2 inhibitor)
Official uses from the US prescribing label

Dapagliflozin tablets are indicated:

  • To reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and either established cardiovascular (CV) disease or multiple CV risk factors.
  • As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Limitations of Use

  • Dapagliflozin tablets are not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus.
  • Dapagliflozin tablets are not recommended for use to improve glycemic control in patients with type 2 diabetes mellitus with an eGFR less than 45 mL/min/1.73 m2. Dapagliflozin tablets are likely to be ineffective in this setting based upon its mechanism of action.

Pediatric use information is approved for AstraZeneca AB’s Farxiga® (dapagliflozin) Tablets. However, due to AstraZeneca AB’s marketing exclusivity rights, this drug product is not labeled with that information.

From the FDA-approved label on DailyMed (published Oct 02, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows DA5 JP. The parts can be split between the two sides, so turn the pill over and check both.
  • It is yellow, round.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold in Canada as AG-Dapagliflozin by Angita Pharma Inc..

In Canada: prescription only.

Ingredients

Active: Dapagliflozin

Other pills with imprint DA5 JP

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Dapagliflozin pills